SWA
NURO

Sutton Wealth Advisors’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Sutton Wealth Advisors’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$229 Hold
40
– – ﹤0.01% 837
2023
Q2 		$312 Buy
+40
New +$370 ﹤0.01% 819

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Sutton Wealth Advisors's NURO Position: Q3 2023 in Review

Sutton Wealth Advisors held its NeuroMetrix, Inc. Common Stock (NURO) position steady in Q3 2023 at 40 shares worth $229. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Sutton Wealth Advisors first reported a position in NURO in Q2 2023 and has held it in 2 quarters since. The position peaked at $312 in Q2 2023. 14 funds tracked by Wall St. Rank hold NURO as of Q3 2023.

  • Sutton Wealth Advisors held 40 shares of NeuroMetrix, Inc. Common Stock worth $229 as of Q3 2023.
  • Sutton Wealth Advisors left its NeuroMetrix, Inc. Common Stock share count unchanged in Q3 2023.
  • NeuroMetrix, Inc. Common Stock made up ﹤0.01% of Sutton Wealth Advisors's portfolio in Q3 2023, its #837 holding.
  • Sutton Wealth Advisors first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2023 and has held it in 2 quarters since.
  • Sutton Wealth Advisors's NeuroMetrix, Inc. Common Stock position peaked at $312 in Q2 2023.
  • 14 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q3 2023.

Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.